- Home
- STAF vs EDSA Comparison
STAF vs EDSA Comparison
Compare STAF & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STAF
- EDSA
- Stock Information
- Founded
- STAF 2009
- EDSA 2015
- Country
- STAF United States
- EDSA Canada
- Employees
- STAF N/A
- EDSA N/A
- Industry
- STAF Professional Services
- EDSA Biotechnology: Pharmaceutical Preparations
- Sector
- STAF Consumer Discretionary
- EDSA Health Care
- Exchange
- STAF Nasdaq
- EDSA Nasdaq
- Market Cap
- STAF 5.2M
- EDSA 6.2M
- IPO Year
- STAF N/A
- EDSA N/A
- Fundamental
- Price
- STAF $3.59
- EDSA $1.85
- Analyst Decision
- STAF
- EDSA Strong Buy
- Analyst Count
- STAF 0
- EDSA 1
- Target Price
- STAF N/A
- EDSA $21.00
- AVG Volume (30 Days)
- STAF 1.1M
- EDSA 17.3K
- Earning Date
- STAF 02-11-2025
- EDSA 02-07-2025
- Dividend Yield
- STAF N/A
- EDSA N/A
- EPS Growth
- STAF N/A
- EDSA N/A
- EPS
- STAF N/A
- EDSA N/A
- Revenue
- STAF $176,819,000.00
- EDSA N/A
- Revenue This Year
- STAF $1.94
- EDSA N/A
- Revenue Next Year
- STAF $8.38
- EDSA N/A
- P/E Ratio
- STAF N/A
- EDSA N/A
- Revenue Growth
- STAF 13.64
- EDSA N/A
- 52 Week Low
- STAF $1.08
- EDSA $1.55
- 52 Week High
- STAF $5.69
- EDSA $5.99
- Technical
- Relative Strength Index (RSI)
- STAF 72.43
- EDSA 44.32
- Support Level
- STAF $2.86
- EDSA $1.65
- Resistance Level
- STAF $3.76
- EDSA $1.94
- Average True Range (ATR)
- STAF 0.33
- EDSA 0.14
- MACD
- STAF 0.14
- EDSA 0.02
- Stochastic Oscillator
- STAF 93.13
- EDSA 45.45
About STAF Staffing 360 Solutions Inc. (DE)
Staffing 360 Solutions Inc operates in the international staffing sector. It is engaged in the execution of an international buy-integrate-build process through the acquisition of domestic and international staffing organizations. The company operates through three Business Streams: Professional Staffing, Commercial Staffing, and Employer of Record. It primarily supports accounting and finance, information technology, engineering, administration, and commercial disciplines.
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.